Skip to main content

Table 1 Characteristics of the study population (n = 868)

From: Gender differences in illness perceptions and disease management in patients with gout, results from a questionnaire study in Western Sweden

Characteristics

Men (n = 691, 80%)

Women (n = 177, 20%)

p-value

Age

70 (12)

75 (12)

< 0.001

Education ≥ 12 years

267 (39)

44 (25)

0.154

Occupational status—Retired

482 (70)

143 (85)

0.002

Disease duration in years

12 (3)

7 (8)

< 0.001

Time since last gout flare

  

0.168

 > 1 year

291 (45)

55 (37)

 

 1–12 months

225 (35)

62 (41)

 

 Last month

131 (20)

33 (22)

 

Pain NRS (0–10)

2.7 (2.5)

4.0 (2.8)

< 0.001

Global NRS (0–10)

2.8 (2.4

3.8 (2.7)

< 0.001

Fatigue NRS (0–10)

3.6 (2.6)

4.4 (2.9)

< 0.001

HAQ score

0.28 (0.51)

0.63 (0.69)

< 0.001

Obesity, BMI ≥ 30.0 kg/m2

154 (22)

60 (34)

< 0.001

Self-reported comorbidities

 Diabetes

157 (23)

40 (23)

0.654

 Kidney disease

55 (8)

18 (11)

0.410

 Hypertension

443 (64)

118 (67)

0.067

 Myocardial infarction

104 (15)

19 (11)

0.311

 Stroke

68 (10)

17 (10)

0.736

Pharmacological treatment

 ULT—allopurinol

341 (49)

87 (49)

0.963

 Diuretics—loop

104 (15)

48 (27)

0.001

 Diuretics – thiazide

69 (11)

27 (15)

0.156

Alcohol use, standard drinks a normal week

  

< 0.001

 No use

84 (13)

60 (36)

 

 < 1

116 (17)

59 (34)

 

 1–4

190 (28)

35 (21)

 

 5–9

190 (28)

13 (8)

 

 10–14

63 (9)

1 (1)

 

 > 15

31 (5)

1 (1)

 
  1. Table 1, Characteristics of the study population stratified by sex, n (%) or mean (SD), students t-test and Chi-square test used for statistical analysis, HAQ Health assessment questionnaire, NRS Numeric rating scale, ULT Urate lowering therapy